Apolipoprotein E polymorphism and cognitive impairment in a Bi-ethnic community-dwelling elderly sample

Dylan G. Harwood, Warren W. Barker, Raymond L. Ownby, Michael Mullan, Ranjan Duara

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The epsilon 4 (ε4) and epsilon 2 (ε2) alleles of the apolipoprotein gene (APOE) located on chromosome 19 have been associated with increased and decreased risk for Alzheimer disease (AD) in older adults, respectively. However, there is a dearth of studies examining the relation of APOE polymorphism with cognitive functioning among community-dwelling ethnic minority elderly. This study examined the risk for cognitive impairment associated with the APOE ε4 and ε2 alleles in a community-based cohort of non-Hispanic white (NHW; N = 739) and white Hispanics (WH; N=321). All patients were recruited consecutively from a memory-screening program and evaluated using standardized assessment procedures. Cognitive impairment was classified according to an age and education adjusted Folstein Mini-Mental State Exam (MMSAdj) score of less than 24. The results indicated the APOE ε4 allele was associated with increased risk for cognitive dysfunction in NHW and WH after controlling for the effects of age, education, and gender. This risk was generally observed to be dose-dependent, with greater risk among ε4 homozygotes in relation to ε4 heterozygotes. The ε2 allele of APOE did not confer decreased risk for cognitive impairment among NHW and WH. This study supports the relation of APOE polymorphism to cognitive dysfunction among two ethnic populations residing in the community.

Original languageEnglish
Pages (from-to)8-14
Number of pages7
JournalAlzheimer Disease and Associated Disorders
Volume16
Issue number1
DOIs
StatePublished - Apr 22 2002
Externally publishedYes

Fingerprint

Independent Living
Apolipoproteins
Apolipoproteins E
Alleles
Genes
Chromosomes, Human, Pair 19
Education
Homozygote
Heterozygote
Hispanic Americans
Cognitive Dysfunction
Alzheimer Disease
Population

Keywords

  • Apolipoprotein E
  • Cognitive impairment
  • Dementia
  • Ethnicity

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Apolipoprotein E polymorphism and cognitive impairment in a Bi-ethnic community-dwelling elderly sample. / Harwood, Dylan G.; Barker, Warren W.; Ownby, Raymond L.; Mullan, Michael; Duara, Ranjan.

In: Alzheimer Disease and Associated Disorders, Vol. 16, No. 1, 22.04.2002, p. 8-14.

Research output: Contribution to journalArticle

Harwood, Dylan G. ; Barker, Warren W. ; Ownby, Raymond L. ; Mullan, Michael ; Duara, Ranjan. / Apolipoprotein E polymorphism and cognitive impairment in a Bi-ethnic community-dwelling elderly sample. In: Alzheimer Disease and Associated Disorders. 2002 ; Vol. 16, No. 1. pp. 8-14.
@article{5a6957085f8a4f0d9f14c9d79fe33b0f,
title = "Apolipoprotein E polymorphism and cognitive impairment in a Bi-ethnic community-dwelling elderly sample",
abstract = "The epsilon 4 (ε4) and epsilon 2 (ε2) alleles of the apolipoprotein gene (APOE) located on chromosome 19 have been associated with increased and decreased risk for Alzheimer disease (AD) in older adults, respectively. However, there is a dearth of studies examining the relation of APOE polymorphism with cognitive functioning among community-dwelling ethnic minority elderly. This study examined the risk for cognitive impairment associated with the APOE ε4 and ε2 alleles in a community-based cohort of non-Hispanic white (NHW; N = 739) and white Hispanics (WH; N=321). All patients were recruited consecutively from a memory-screening program and evaluated using standardized assessment procedures. Cognitive impairment was classified according to an age and education adjusted Folstein Mini-Mental State Exam (MMSAdj) score of less than 24. The results indicated the APOE ε4 allele was associated with increased risk for cognitive dysfunction in NHW and WH after controlling for the effects of age, education, and gender. This risk was generally observed to be dose-dependent, with greater risk among ε4 homozygotes in relation to ε4 heterozygotes. The ε2 allele of APOE did not confer decreased risk for cognitive impairment among NHW and WH. This study supports the relation of APOE polymorphism to cognitive dysfunction among two ethnic populations residing in the community.",
keywords = "Apolipoprotein E, Cognitive impairment, Dementia, Ethnicity",
author = "Harwood, {Dylan G.} and Barker, {Warren W.} and Ownby, {Raymond L.} and Michael Mullan and Ranjan Duara",
year = "2002",
month = "4",
day = "22",
doi = "10.1097/00002093-200201000-00002",
language = "English",
volume = "16",
pages = "8--14",
journal = "Alzheimer Disease and Associated Disorders",
issn = "0893-0341",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Apolipoprotein E polymorphism and cognitive impairment in a Bi-ethnic community-dwelling elderly sample

AU - Harwood, Dylan G.

AU - Barker, Warren W.

AU - Ownby, Raymond L.

AU - Mullan, Michael

AU - Duara, Ranjan

PY - 2002/4/22

Y1 - 2002/4/22

N2 - The epsilon 4 (ε4) and epsilon 2 (ε2) alleles of the apolipoprotein gene (APOE) located on chromosome 19 have been associated with increased and decreased risk for Alzheimer disease (AD) in older adults, respectively. However, there is a dearth of studies examining the relation of APOE polymorphism with cognitive functioning among community-dwelling ethnic minority elderly. This study examined the risk for cognitive impairment associated with the APOE ε4 and ε2 alleles in a community-based cohort of non-Hispanic white (NHW; N = 739) and white Hispanics (WH; N=321). All patients were recruited consecutively from a memory-screening program and evaluated using standardized assessment procedures. Cognitive impairment was classified according to an age and education adjusted Folstein Mini-Mental State Exam (MMSAdj) score of less than 24. The results indicated the APOE ε4 allele was associated with increased risk for cognitive dysfunction in NHW and WH after controlling for the effects of age, education, and gender. This risk was generally observed to be dose-dependent, with greater risk among ε4 homozygotes in relation to ε4 heterozygotes. The ε2 allele of APOE did not confer decreased risk for cognitive impairment among NHW and WH. This study supports the relation of APOE polymorphism to cognitive dysfunction among two ethnic populations residing in the community.

AB - The epsilon 4 (ε4) and epsilon 2 (ε2) alleles of the apolipoprotein gene (APOE) located on chromosome 19 have been associated with increased and decreased risk for Alzheimer disease (AD) in older adults, respectively. However, there is a dearth of studies examining the relation of APOE polymorphism with cognitive functioning among community-dwelling ethnic minority elderly. This study examined the risk for cognitive impairment associated with the APOE ε4 and ε2 alleles in a community-based cohort of non-Hispanic white (NHW; N = 739) and white Hispanics (WH; N=321). All patients were recruited consecutively from a memory-screening program and evaluated using standardized assessment procedures. Cognitive impairment was classified according to an age and education adjusted Folstein Mini-Mental State Exam (MMSAdj) score of less than 24. The results indicated the APOE ε4 allele was associated with increased risk for cognitive dysfunction in NHW and WH after controlling for the effects of age, education, and gender. This risk was generally observed to be dose-dependent, with greater risk among ε4 homozygotes in relation to ε4 heterozygotes. The ε2 allele of APOE did not confer decreased risk for cognitive impairment among NHW and WH. This study supports the relation of APOE polymorphism to cognitive dysfunction among two ethnic populations residing in the community.

KW - Apolipoprotein E

KW - Cognitive impairment

KW - Dementia

KW - Ethnicity

UR - http://www.scopus.com/inward/record.url?scp=0036220418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036220418&partnerID=8YFLogxK

U2 - 10.1097/00002093-200201000-00002

DO - 10.1097/00002093-200201000-00002

M3 - Article

VL - 16

SP - 8

EP - 14

JO - Alzheimer Disease and Associated Disorders

JF - Alzheimer Disease and Associated Disorders

SN - 0893-0341

IS - 1

ER -